Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration

scientific article published on November 2000

Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1074/JBC.M006613200
P698PubMed publication ID10969084

P2093author name stringLee JM
Chan G
White JR
Foley JJ
Sarau HM
Schmidt DB
Christmann LT
Darcy MG
Dhanak D
Fornwald JA
Jurewicz AJ
Widdowson KL
Imburgia CS
Dede K
P2860cites workThe CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3Q57019223
C-C Chemokine Receptor 3 Antagonism by the -Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine SwapQ57130759
Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistQ59065030
Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor bindingQ67485755
Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pigQ68281630
Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid productionQ72376935
The inflammatory nature of allergic diseaseQ78167508
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1Q22010429
Identification of receptors for neuromedin U and its role in feedingQ22254611
Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2BQ24312103
Selective expression of the eotaxin receptor CCR3 by human T helper 2 cellsQ24312942
Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibodyQ24561853
The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytesQ24653022
Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytesQ24669740
Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPRQ24675425
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophilsQ24678192
Cloning, expression, and characterization of the human eosinophil eotaxin receptorQ24678271
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammationQ24680123
Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3Q28278947
Cloning and functional expression of a human eosinophil CC chemokine receptorQ28294129
A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptorQ28343083
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activityQ28343321
A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.Q31395542
Pathogenesis of atopic dermatitisQ33731176
Chemokines active on eosinophils: potential roles in allergic inflammationQ36366779
Properties of the novel proinflammatory supergene "intercrine" cytokine family.Q37357898
Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokinesQ37364354
Eotaxin: a VIC (very important chemokine) of allergic inflammation?Q39759595
Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptorsQ40920168
Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptorQ41032296
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.Q41071776
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.Q41091668
Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist.Q41229926
Characterisation of the RANTES/MIP-1 alpha receptor (CC CKR-1) stably transfected in HEK 293 cells and the recombinant ligands.Q41269142
Chemokines: what chemokine is that?Q41510862
Chemokine receptors and T cell chemotaxisQ42016350
The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsivenessQ42417164
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migrationQ42543239
Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs.Q42596329
Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophiliaQ42947733
Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscleQ43260751
An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophilsQ43750645
Effect of the dopamine beta-hydroxylase inhibitor, SK&F 102698, on blood pressure in the 1-kidney, 1-clip hypertensive dog.Q50136474
P433issue47
P407language of work or nameEnglishQ1860
P921main subjectchemotaxisQ658145
P304page(s)36626-36631
P577publication date2000-11-01
P1433published inJournal of Biological ChemistryQ867727
P1476titleIdentification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration
P478volume275

Reverse relations

cites work (P2860)
Q34994975Asthma: future directions
Q35743287Biochemical assessment of intracellular signal transduction pathways in eosinophils: implications for pharmacotherapy
Q44795042CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.
Q92146450CCR3 antagonist impairs estradiol-induced eosinophil migration to the uterus in ovariectomized mice
Q35091280CCR3: a key to mast cell phenotypic and functional diversity?
Q37481238Chemokine receptor antagonists: Part 1.
Q37721300Chemokines and their receptors in the allergic airway inflammatory process.
Q37442685Chemokines as possible targets in modulation of the secondary damage after acute spinal cord injury: a review.
Q40220734Chemokines induce axon outgrowth downstream of Hepatocyte Growth Factor and TCF/β-catenin signaling
Q35561670Cytokine-directed therapies for the treatment of chronic airway diseases
Q30671170Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1.
Q43621563Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.
Q37039453Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites
Q79949175Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects
Q41875485Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis.
Q28362893Eotaxin and the attraction of eosinophils to the asthmatic lung
Q30779108Functional inhibition of CCR3-dependent responses by peptides derived from phage libraries
Q35065927G protein-coupled receptors--recent advances
Q53653346Identification and characterization of novel antagonists of the CCR3 receptor.
Q40687718Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS binding
Q57462537Increased serum Th2 chemokine levels are associated with bronchopulmonary dysplasia in premature infants
Q44636885Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor
Q34743328New therapeutics that modulate chemokine networks
Q37415334Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.
Q57181974Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness
Q42024121PI3K, ERK, p38 MAPK and integrins regulate CCR3-mediated secretion of mouse and human eosinophil-associated RNases
Q27003331Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field
Q36201583Pharmacological management of nasal polyposis
Q38196934Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4.
Q44031732Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists
Q53328522Role of chemokine (C-C motif) ligand 24 in spatial arrangement of the inner cell mass of the bovine embryo.
Q34734980Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation
Q47271733Selective suppression of Th2-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonists.
Q36165903Selective suppression of leukocyte recruitment in allergic inflammation
Q37670242Targeting CCL11 in the treatment of ovarian cancer
Q54109145The Orphan G Protein-coupled Receptor 75 Signaling is Activated by the Chemokine CCL5.
Q37738100The role of local steroid injection for nasal polyposis

Search more.